康哲藥業業績拐點確立：創新藥與獨家藥接棒增長 新藥進入密集兌現期
Mar 20, 2026 20:08 HKT |  |
|
Aleen Inc. Insights: Exploring LOINC Standard to Enhance Wellness Data Consistency
Mar 18, 2026 23:40 HKT |  |
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT | |
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT | |
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT | |
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT |  |
|
康哲藥業：磷酸蘆可替尼乳膏（百盧妥(R)）在中國多地實現白癜風首批處方落地
Mar 13, 2026 16:45 HKT | |
|
康哲药业：磷酸芦可替尼乳膏（百卢妥(R)）在中国多地实现白癜风首批处方落地
Mar 13, 2026 16:35 HKT | |
|
OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share
Mar 12, 2026 18:07 HKT |  |
|
OMRON Healthcare releases new Women's Heart Health Factbook
Mar 09, 2026 06:00 HKT |  |
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 05, 2026 16:00 HKT | |
|
康哲药业自研INHBE小核酸药物获批超重/肥胖临床
Mar 05, 2026 15:13 HKT | |
|
康哲藥業自研INHBE小核酸藥物獲批超重/肥胖臨床
Mar 05, 2026 15:02 HKT | |
|
兩會焦點：腦機接口破圈！從「腦器交互」到產業落地 產學研共啟萬億新賽道
Mar 04, 2026 16:56 HKT | |
|
愛康醫療(1789.HK)獲納入中證港股通機器人主題指數 凸顯機器人領域投資潛力
Mar 03, 2026 10:45 HKT |  |
|
爱康医疗(1789.HK)获纳入中证港股通机器人主题指数 凸显机器人领域投资潜力
Mar 03, 2026 10:36 HKT | |
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 25, 2026 19:57 HKT |  |
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT | |
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT | |
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT | |
|